People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

116.60CHF
23 Dec 2014
Price Change (% chg)

CHF-2.00 (-1.69%)
Prev Close
CHF118.60
Open
CHF119.10
Day's High
CHF120.40
Day's Low
CHF116.40
Volume
383,671
Avg. Vol
512,231
52-wk High
CHF120.40
52-wk Low
CHF74.20

Search Stocks

Clozel, Martine 

Brief Biography

Ms. Martine Clozel has been Member of the Management Board, Senior Vice President, Chief Scientific Officer at Actelion Ltd since 2009. She has served as Senior Vice President, Head of Drug Discovery, Pharmacology & Pre-clinical Development since 1997. She is one of the founders of the Company. She is Pediatrician specialized in neonatal intensive care, educated at Universite Henri Poincare - Nancy I. She also took training in Physiology and pharmacology at McGill University, Montreal, and at University of California. She was Assistant Professor in Neonatology. She was Scientific Expert, Leader drug discovery projects at F. Hoffman-La Roche.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks